These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
90 related articles for article (PubMed ID: 1719328)
1. Disposition of fluorescein-labelled dextran (150 kD) in isolated perfused livers from control and diabetic rats. Mehvar R; Reynolds JM; Shepard TL Life Sci; 1991; 49(23):1699-706. PubMed ID: 1719328 [TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of 70-kilodalton fluorescein-dextran in experimental diabetes mellitus. Mehvar R; Reynolds JM J Pharmacol Exp Ther; 1993 Feb; 264(2):662-9. PubMed ID: 7679734 [TBL] [Abstract][Full Text] [Related]
3. Kinetics of hepatic accumulation of dextrans in isolated perfused rat livers. Mehvar R Drug Metab Dispos; 1997 May; 25(5):552-6. PubMed ID: 9152593 [TBL] [Abstract][Full Text] [Related]
4. Diabetes-induction reduction in the hepatic accumulation of 70-kDA dextran: role of hyperglycemia and hypoinsulinemia. Mehvar R; Reynolds J J Pharm Sci; 1994 Jul; 83(7):1020-5. PubMed ID: 7525920 [TBL] [Abstract][Full Text] [Related]
5. Evaluation of changes in hepatic disposition of phenolsulfonphthalein, indocyanine green and fluorescein isothiocyanate-dextran at low temperatures using a rat liver perfusion system. Miyamoto H; Miyake H; Yoshikawa N; Hirata H; Ohwaki Y; Fumoto S; Sasaki H; Nakamura J; Nishida K J Pharm Pharmacol; 2012 Jun; 64(6):848-54. PubMed ID: 22571263 [TBL] [Abstract][Full Text] [Related]
8. Hepatic disposition of cyclosporine A in isolated perfused rat livers. Mehvar R; Chimalakonda AP J Pharm Pharm Sci; 2004 Feb; 7(1):47-54. PubMed ID: 15144734 [TBL] [Abstract][Full Text] [Related]
9. A quantitative study of fluorescein isothiocyanate-dextran transport in the microcirculation of the isolated perfused rat liver. Stock RJ; Cilento EV; McCuskey RS Hepatology; 1989 Jan; 9(1):75-82. PubMed ID: 2461894 [TBL] [Abstract][Full Text] [Related]
13. Disposition of a polymeric prodrug of mitomycin C, mitomycin C-dextran conjugate, in the perfused rat liver. Sato K; Itakura K; Nishida K; Takakura Y; Hashida M; Sezaki H J Pharm Sci; 1989 Jan; 78(1):11-6. PubMed ID: 2468759 [TBL] [Abstract][Full Text] [Related]
14. Polysaccharides as drug carriers: biodisposition of fluorescein-labeled dextrans in mice. Kaneo Y; Uemura T; Tanaka T; Kanoh S Biol Pharm Bull; 1997 Feb; 20(2):181-7. PubMed ID: 9057983 [TBL] [Abstract][Full Text] [Related]
16. Dose dependency of the kinetics of dextrans in rats: effects of molecular weight. Mehvar R; Robinson MA; Reynolds JM J Pharm Sci; 1995 Jul; 84(7):815-8. PubMed ID: 7562429 [TBL] [Abstract][Full Text] [Related]
17. Lipogenesis from ketone bodies in perfused livers from streptozocin-induced diabetic rats. Freed LE; Endemann G; Tomera JF; Gavino VC; Brunengraber H Diabetes; 1988 Jan; 37(1):50-5. PubMed ID: 3335277 [TBL] [Abstract][Full Text] [Related]
18. Molecular weight dependent tissue accumulation of dextrans: in vivo studies in rats. Mehvar R; Robinson MA; Reynolds JM J Pharm Sci; 1994 Oct; 83(10):1495-9. PubMed ID: 7533835 [TBL] [Abstract][Full Text] [Related]
19. Adenine nucleotides and carbohydrates in subpopulations of hepatic nodules with normal and compromised microcirculation. Anundi I; Kauffman FC; te Koppele JM; Yamanaka H; Whittaker M; Popp JA; Thurman RG Cancer Res; 1989 Jun; 49(12):3282-6. PubMed ID: 2470503 [TBL] [Abstract][Full Text] [Related]
20. Effect of diabetes on triiodothyronine and reverse triiodothyronine production in the perfused rat liver and kidney. Ikeda T; Ito Y; Murakami I; Mokuda O; Kuno S; Tokumori Y; Tominaga M; Mashiba H Diabetes; 1985 Jul; 34(7):647-52. PubMed ID: 4007285 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]